Characterization of MET exon 14 skipping in Chinese non-small cell lung cancer (NSCLC) patients.

e21525Background: MET exon 14 skipping (METex14) has been identified as a precise biomarker for MET-targeted therapy. Most METex14 alterations occur in patients (pts) with non-small cell lung cance...